BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xing C, Li Y, Ding C, Wang S, Zhang H, Chen L, Li P, Dai M. CD44+ Circulating Tumor Endothelial Cells Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After Radical Surgery: A Pilot Study. Cancer Manag Res 2021;13:4417-31. [PMID: 34103996 DOI: 10.2147/CMAR.S309115] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Maiborodin I, Mansurova A, Chernyavskiy A, Romanov A, Voitcitctkii V, Kedrova A, Tarkhov A, Chernyshova A, Krasil’nikov S. Cancer Angiogenesis and Opportunity of Influence on Tumor by Changing Vascularization. JPM 2022;12:327. [DOI: 10.3390/jpm12030327] [Reference Citation Analysis]
2 Bandini E, Rossi T, Scarpi E, Gallerani G, Vannini I, Salvi S, Azzali I, Melloni M, Salucci S, Battistelli M, Serra P, Maltoni R, Cho WC, Fabbri F. Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer. Front Mol Biosci 2021;8:732900. [PMID: 34820420 DOI: 10.3389/fmolb.2021.732900] [Reference Citation Analysis]
3 Lin AY, Wang DD, Li L, Lin PP. Identification and Comprehensive Co-Detection of Necrotic and Viable Aneuploid Cancer Cells in Peripheral Blood. Cancers (Basel) 2021;13:5108. [PMID: 34680256 DOI: 10.3390/cancers13205108] [Reference Citation Analysis]
4 Zhang T, Zhang L, Gao Y, Wang Y, Liu Y, Zhang H, Wang Q, Hu F, Li J, Tan J, Wang DD, Gires O, Lin PP, Li B. Role of aneuploid circulating tumor cells and CD31+ circulating tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced NSCLC. Mol Oncol 2021;15:2891-909. [PMID: 34455700 DOI: 10.1002/1878-0261.13092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]